Study of TPEx Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the H&N
Clinical trial NCT06640725 · RECRUITING
Trial details
- NCT number
- NCT06640725
- Sponsor
- Groupe Oncologie Radiotherapie Tete et Cou
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2027-10-02
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.